The Clorox Company (NYSE:CLX) Receives Average Recommendation of “Reduce” from Analysts

Shares of The Clorox Company (NYSE:CLXGet Free Report) have received an average rating of “Reduce” from the fourteen ratings firms that are currently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $159.62.

Several equities research analysts have recently issued reports on CLX shares. Wells Fargo & Company lifted their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Barclays upped their price objective on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th.

View Our Latest Research Report on CLX

Clorox Trading Down 0.8 %

CLX stock opened at $143.75 on Tuesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The business has a 50 day simple moving average of $152.57 and a two-hundred day simple moving average of $159.59. The company has a market capitalization of $17.71 billion, a price-to-earnings ratio of 39.28, a PEG ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the business earned $2.16 earnings per share. Research analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.39%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.

Institutional Trading of Clorox

Large investors have recently made changes to their positions in the stock. Brooklyn Investment Group increased its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the period. Redwood Park Advisors LLC purchased a new position in shares of Clorox during the fourth quarter worth approximately $26,000. Prospera Private Wealth LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC boosted its holdings in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the period. Finally, Millstone Evans Group LLC bought a new position in Clorox in the fourth quarter worth approximately $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.